VICTORY CAPITAL MANAGEMENT INC

Position in ABSI — Absci Corp

CIK 1040188 San Antonio, TX

Position in ABSI

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,756,290

+$1,303,293 QoQ

Shares Held

151,535

+0.4% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 195 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. ABSI ranks #59 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,756,290	151,535	+0.4%	Shares	Sole	2026-08-07
2026-03-31	$452,997	150,999	-0.8%	Shares	Sole	2026-05-15
2025-12-31	$531,478	152,286	+0.4%	Shares	Sole	2026-02-13
2025-09-30	$461,119	151,684	+0.9%	Shares	Sole	2025-11-12
2025-06-30	$386,404	150,352	+3.0%	Shares	Sole	2025-08-13
2025-03-31	$366,342	145,953	-0.9%	Shares	Sole	2025-05-02
2024-12-31	$385,802	147,253	-2.2%	Shares	Sole	2025-02-06
2024-09-30	$575,146	150,562	+5.9%	Shares	Sole	2024-11-05
2024-06-30	$437,895	142,174	-23.5%	Shares	Sole	2024-08-05
2024-03-31	$1,055,616	185,848	+208.2%	Shares	Sole	2024-05-03
2022-06-30	$200,229	60,310	0.0%	Shares	Sole	2022-08-01
2022-03-31	$508,413	60,310	-4.1%	Shares	Sole	2022-05-04
2021-12-31	$515,616	62,880	-5.0%	Shares	Sole	2022-02-07
2021-09-30	$769,557	66,170	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.